207 related articles for article (PubMed ID: 35915689)
1. 3,4-Methylenedioxymethamphetamine (MDMA)-Assisted Therapy in Hawaii: A Brief Review.
Inouye A; Wolfgang A
Cureus; 2022 Jun; 14(6):e26402. PubMed ID: 35915689
[TBL] [Abstract][Full Text] [Related]
2. A Review of MDMA-Assisted Therapy for Posttraumatic Stress Disorder.
Lewis BR; Byrne K
Focus (Am Psychiatr Publ); 2023 Jul; 21(3):247-256. PubMed ID: 37404966
[TBL] [Abstract][Full Text] [Related]
3. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial.
Mithoefer MC; Mithoefer AT; Feduccia AA; Jerome L; Wagner M; Wymer J; Holland J; Hamilton S; Yazar-Klosinski B; Emerson A; Doblin R
Lancet Psychiatry; 2018 Jun; 5(6):486-497. PubMed ID: 29728331
[TBL] [Abstract][Full Text] [Related]
4. Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline.
Feduccia AA; Jerome L; Yazar-Klosinski B; Emerson A; Mithoefer MC; Doblin R
Focus (Am Psychiatr Publ); 2023 Jul; 21(3):306-314. PubMed ID: 37404974
[TBL] [Abstract][Full Text] [Related]
5. Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline.
Feduccia AA; Jerome L; Yazar-Klosinski B; Emerson A; Mithoefer MC; Doblin R
Front Psychiatry; 2019; 10():650. PubMed ID: 31572236
[TBL] [Abstract][Full Text] [Related]
6. MDMA-Based Psychotherapy in Treatment-Resistant Post-Traumatic Stress Disorder (PTSD): A Brief Narrative Overview of Current Evidence.
Riaz K; Suneel S; Hamza Bin Abdul Malik M; Kashif T; Ullah I; Waris A; Di Nicola M; Mazza M; Sani G; Martinotti G; De Berardis D
Diseases; 2023 Nov; 11(4):. PubMed ID: 37987270
[TBL] [Abstract][Full Text] [Related]
7. Review of potential psychedelic treatments for PTSD.
Henner RL; Keshavan MS; Hill KP
J Neurol Sci; 2022 Aug; 439():120302. PubMed ID: 35700643
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for posttraumatic stress disorder: A systematic review and meta-analysis.
Bahji A; Forsyth A; Groll D; Hawken ER
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Jan; 96():109735. PubMed ID: 31437480
[TBL] [Abstract][Full Text] [Related]
9. Psilocybin and MDMA for the treatment of trauma-related psychopathology.
Bird CIV; Modlin NL; Rucker JJH
Int Rev Psychiatry; 2021 May; 33(3):229-249. PubMed ID: 34121583
[TBL] [Abstract][Full Text] [Related]
10. A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy.
Sessa B; Higbed L; Nutt D
Front Psychiatry; 2019; 10():138. PubMed ID: 30949077
[TBL] [Abstract][Full Text] [Related]
11. MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials.
Mithoefer MC; Feduccia AA; Jerome L; Mithoefer A; Wagner M; Walsh Z; Hamilton S; Yazar-Klosinski B; Emerson A; Doblin R
Psychopharmacology (Berl); 2019 Sep; 236(9):2735-2745. PubMed ID: 31065731
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials.
Jerome L; Feduccia AA; Wang JB; Hamilton S; Yazar-Klosinski B; Emerson A; Mithoefer MC; Doblin R
Psychopharmacology (Berl); 2020 Aug; 237(8):2485-2497. PubMed ID: 32500209
[TBL] [Abstract][Full Text] [Related]
13. A randomized, controlled pilot study of MDMA (± 3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD).
Oehen P; Traber R; Widmer V; Schnyder U
J Psychopharmacol; 2013 Jan; 27(1):40-52. PubMed ID: 23118021
[TBL] [Abstract][Full Text] [Related]
14. A comparison of MDMA-assisted psychotherapy to non-assisted psychotherapy in treatment-resistant PTSD: A systematic review and meta-analysis.
Illingworth BJ; Lewis DJ; Lambarth AT; Stocking K; Duffy JM; Jelen LA; Rucker JJ
J Psychopharmacol; 2021 May; 35(5):501-511. PubMed ID: 33345689
[TBL] [Abstract][Full Text] [Related]
15. Perceived key change phenomena of MDMA-assisted psychotherapy for the treatment of severe PTSD: an interpretative phenomenological analysis of clinical integration sessions.
Godes M; Lucas J; Vermetten E
Front Psychiatry; 2023; 14():957824. PubMed ID: 37484678
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic role of psilocybin and 3,4-methylenedioxymethamphetamine in trauma: A literature review.
Fonseka LN; Woo BK
World J Psychiatry; 2023 May; 13(5):182-190. PubMed ID: 37303932
[TBL] [Abstract][Full Text] [Related]
17. MDMA-assisted therapy for posttraumatic stress disorder: A pooled analysis of ethnoracial differences in efficacy and safety from two Phase 2 open-label lead-in trials and a Phase 3 randomized, blinded placebo-controlled trial.
Ching TH; Williams MT; Wang JB; Jerome L; Yazar-Klosinski B; Emerson A; Doblin R
J Psychopharmacol; 2022 Aug; 36(8):974-986. PubMed ID: 35727042
[TBL] [Abstract][Full Text] [Related]
18. Effects of Selective Serotonin Reuptake Inhibitor Use on 3,4-Methylenedioxymethamphetamine-Assisted Therapy for Posttraumatic Stress Disorder: A Review of the Evidence, Neurobiological Plausibility, and Clinical Significance.
Price CM; Feduccia AA; DeBonis K
J Clin Psychopharmacol; 2022 Sep-Oct 01; 42(5):464-469. PubMed ID: 36018231
[TBL] [Abstract][Full Text] [Related]
19. The Efficacy of MDMA (3,4-Methylenedioxymethamphetamine) for Post-traumatic Stress Disorder in Humans: A Systematic Review and Meta-Analysis.
Tedesco S; Gajaram G; Chida S; Ahmad A; Pentak M; Kelada M; Lewis L; Krishnan D; Tran C; Soetan OT; Mukona LT; Jolayemi A
Cureus; 2021 May; 13(5):e15070. PubMed ID: 34150406
[No Abstract] [Full Text] [Related]
20. MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study.
Mitchell JM; Bogenschutz M; Lilienstein A; Harrison C; Kleiman S; Parker-Guilbert K; Ot'alora G M; Garas W; Paleos C; Gorman I; Nicholas C; Mithoefer M; Carlin S; Poulter B; Mithoefer A; Quevedo S; Wells G; Klaire SS; van der Kolk B; Tzarfaty K; Amiaz R; Worthy R; Shannon S; Woolley JD; Marta C; Gelfand Y; Hapke E; Amar S; Wallach Y; Brown R; Hamilton S; Wang JB; Coker A; Matthews R; de Boer A; Yazar-Klosinski B; Emerson A; Doblin R
Nat Med; 2021 Jun; 27(6):1025-1033. PubMed ID: 33972795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
